Solid Biosciences upgraded by JP Morgan with a new price target
$SLDB
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
JP Morgan upgraded Solid Biosciences from Neutral to Overweight and set a new price target of $15.00 from $10.00 previously